R. Donald Harvey

Emory University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Bortezomib-induced peripheral neuropathy appears to be higher in patients who self-report as Black.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Juno Obedin-Maliver

Stanford University School of Medicine

UNITED STATES

View details

Deanna Attai

Assistant Clinical Professor

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Evan Hall

Assistant Professor

University of Washington

UNITED STATES

View details

Nisha Joseph

Associate Professor

Winship Cancer Institute of Emory University

UNITED STATES

View details

Xiudong Lei

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

R. Donald Harvey

Research Interests

Explore related searches

Contact this professor

Articles (14)

Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement

A call to action to advance patient‐focused and decentralized clinical trials

Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction

Debunking Sex and Disentangling Gender From Oncology

The earlier the better? Or better late than never? Dose optimization in oncology

Race‐free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment

Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer

Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation

Call to Action for Improving Oral Anticancer Agent Adherence

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group

Collaborators (5)

Juno Obedin-Maliver

Deanna Attai

Evan Hall

Nisha Joseph

Xiudong Lei

Make your next move.